Design Therapeutics Sets IPO Offering Range
MARCH 23, 2021
Carlsbad-based Design Therapeutics, a company developing treatments for serious degenerative disorders, has set an expected IPO offering range of between $18.00 design therapeutics small molecule merger acquisition biotech lifescience geneand $20.00 per share, the company said in a filing this week. The company has applied to list on the Nasdaq Global Market as DSGN. The company is venture backed by SR One, Quan Capital, Cormorant Asset Management, and WestRiver Group.